Pesquisar
Nervgen Pharma Ord Shs
NGENAdicionar à lista de desejos
2.020USD
+0.060+3.06%
Fechamento 09-24 16:00（ET）
214.50MValor de mercado
PerdaP/L TTM
Sobre o Nervgen Pharma Ord Shs Empresa
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Nervgen Pharma Ord Shs Perfil
Código da empresaNGEN
Nome da EmpresaNervGen Pharma Corp
Data de listagemMar 13, 2019
CEORogers (Adam H)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscal- -
EndereçoSuite 1703 - 595 Burrard Street
CidadeVANCOUVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísCanada
Código postalV7X 1J1
Telefone16047225361
Sitehttps://www.nervgen.com/
Código da empresaNGEN
Data de listagemMar 13, 2019
CEORogers (Adam H)
Executivos da empresa Nervgen Pharma Ord Shs
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
168.97K
+5.31%
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
168.97K
+5.31%
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
168.97K
+5.31%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
45.38K
+38.84%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
45.38K
+38.84%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
45.38K
+38.84%
,
,
--
--
Mr. Brian Eric Bayley
Mr. Brian Eric Bayley
Independent Director
Independent Director
--
--
Dr. Harold Martin Punnett
Dr. Harold Martin Punnett
Independent Director
Independent Director
--
--
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
168.97K
+5.31%
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
168.97K
+5.31%
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
168.97K
+5.31%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
45.38K
+38.84%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
45.38K
+38.84%
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
45.38K
+38.84%
Perguntas frequentes
Quem são os cinco principais acionistas de Nervgen Pharma Ord Shs?
Os cinco principais acionistas de Nervgen Pharma Ord Shs são: Dr. Randall E. Kaye, M.D.
Quantas instituições possuem ações da Nervgen Pharma Ord Shs (NGEN)?
Em 2026Q1, 17 instituições possuíam ações da Nervgen Pharma Ord Shs, com valor de mercado aproximado de 350.93K, representando 0.44% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 303132.00.